Channel Avatar

RETINADO D @UCdBVSsN_FrJjq54KQ-Q9ulw@youtube.com

360 subscribers - no pronouns :c

Eduardo Buchele Rodrigues has worked as Editor of a Journal


04:38
Retina Clinics. III. AI - Chat GPT for medical chart documentation!
02:44
Retinal Astrocytic Hamartoma. II.Association with tuberous sclerosis
01:59
BLIP. Benign Lobular Inner Nuclear Layer Proliferations. I. Overview.
05:04
Basic science. II. Cells involved in retinal phototransduction
03:23
Red Eye Syndrome. II. Chronic conjunctivitis overview
06:09
Neuro-ophthalmology. I. Irlen Syndrome
05:04
Leukemia & Eye. I. Image discussion & introduction
08:29
Systemic syndromes & Eye. I. Wolfram syndrome
05:27
PHOMS - Peripapillary Hyperreflective Ovoid Mass-Like Structures. I. Introduction
04:59
Scientific papers. II. Truckee study. Real world data of faricimab for neovascular AMD
03:10
Scientific articles. I. Introduction to the International Journal of Retina and Vitreous
03:09
Optic disk melanocytoma. I. Overview
02:37
Retinitis. I. Cat scratch disease
03:00
Epiretinal membranes. III. Secondary to silicone oil
05:33
Pachychoroid spectrum diseases. I. I. Venous overload choroidopathy concept
03:33
Red Eye Syndrome. I. Differential diagnosis
03:43
Dry Age-related macular degeneration. V. Introduction to intravitreal Pegcetacoplan
03:43
Peripheral retinal degeneration. I. what is lattice degeneration
02:42
Vitreous hemorrhage. II. When to operate ?
04:50
Retina Clinics. II. How to improve your assessment
03:33
Ocular Syphilis. II. Diagnostic tests
03:27
Ocular Syphilis. I. Introduction
03:41
Retinal detachment surgery. IV. History & indications of scleral buckle
04:52
Visual electrophysiology. II. Indications of each exam
02:22
Ozurdex intravitreal dexamethasone implant. I. Main indications
02:38
Clarus 700 Fundus Camera. I. Overview.
08:16
Wet Age-related Macular Degeneration. IV. When to switch anti-VEGF agents
06:10
Dry AMD. I. Zimura: 12-months results of the Gather2 trial
05:41
Diabetic Macular Edema (DME). II.When to switch anti-VEGF agents
02:46
Commotio Retinae. I. Intro & pathophysiology
04:30
Wet AMD. III. When to stop intravitreal injections
01:36
Fluorescein angiography. III. Oral Administration in Children
03:21
Immunology. II. Introduction to Complement System
03:40
Polypoidal Choroidal Vasculopathy. I. Introduction & concepts
04:36
Retina Clinics. I. How to perform a good assessment
03:25
Retinal Hemangioblastoma. I. Introduction & Concepts
01:58
Extensive macular atrophy with pseudodrusen (EMAP). I. Introduction
03:16
Vitrectomy. I. Basic concepts of fluidics
04:53
Immunology. I. Cells of the innate response
02:38
Suprachoroidal drug delivery. I. Introduction
05:46
Retina Dystrophies. I. Assessment
02:58
Fluorescein angiography. II. Oral Administration
01:46
Intravitreal injections. II. First syringe approved for ophthalmology.
02:17
Anomalous PVD. I. Pathophysiology
01:43
Macular holes. V. Is there a role for autologous retina transplant?
04:06
Macular holes. IV. Types of surgical outcomes
02:37
Macular holes. III. Size
05:06
Macular holes. II. Pathogenesis
05:15
Macular holes. I. Techniques
03:26
EOG. I. Introduction
01:53
Vitreomacular traction. I. Predisposing factors of spontaneous resolution
01:39
Dry age-related macular degeneration. III. Classification
07:04
Dry Age-related macular degeneration. II. Types of drusen
04:02
Ocular Bartonellosis. I. A case in an immunosuppressed adult.
04:38
Clinical trials for diabetic retinopathy. Introduction to Protocol W
02:18
Ocular Venous Air Embolism. I. Indication for vitrectomy time-out
03:24
Clinical trials for diabetic retinopathy. Introduction to Protocol T
02:31
Retinal Vasculitis. I. Definition & Causes
03:28
Visual Electrophysiology. I. How to choose the right exam?
04:28
Choroidal Detachment. II. Diagnosis & Management